Table 1.
Demographic and Clinical Characteristics of Asymptomatic SARS-CoV-2 Seropositive and highly exposed Seronegative Individuals test (Chi-Square 7.66, p-value 0.36).
| Group | Group A | Group B | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Seropositive, asymptomatic | Seronegative highly exposed | ||||||||
| Total number | 43 | 52 | |||||||
| Age | 1–20 | 21–40 | 41–63 | >64 | 1–20 | 21–40 | 41–63 | >64 | |
| Number | 8 | 16 | 17 | 2 | 17 | 11 | 19 | 5 | |
| Sex | Male | 5 | 11 | 11 | 2 | 10 | 4 | 8 | 4 |
| Female | 3 | 5 | 6 | 0 | 7 | 7 | 11 | 1 | |
| Risk Factors Associated with Severe COVID19 Disease* | |||||||||
| Diabetes | Male | 1 | |||||||
| Female | 1 | ||||||||
| Hypertension | 5 | 1 | 1 | 2 | |||||
| Serious heart conditions | 1 | ||||||||
| Cystic fibrosis | 1 | ||||||||
| Chronic kidney disease | 1 | ||||||||
| Liver disease | 1 | ||||||||
| Cerebrovascular disease (affects blood vessels and blood supply to the brain) | |||||||||
| Immunocompromised state | 2 | 1 | |||||||
| Cancer | 1 | 1 | |||||||
| Obesity (BMI >30) | male | 2 | 1 | 1 | 2 | ||||
| female | 1 | 1 | |||||||
| Patients reporting new symptoms post exposure (Fatigue, lung or cardiac SOB) | none | none | none | none | none | none | none | none | |